Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccine research
Biotech
John Mascola moves on from NIAID's R&D hub—Chutes and Ladders
Mascola leaves VRC after 22 years, including nine as director. Former Merck CEO Frazier joins colleagues at Eikon. Bone ditches four C-suite members.
Max Bayer
Apr 1, 2022 9:30am
John Mascola reflects on leading NIAID's 'NASA-type incubator'
Mar 30, 2022 9:25am
NIAID vaccine chief who collaborated with Moderna to retire
Feb 16, 2022 12:41pm
